Advancing protozoan vaccine research: A review of promising candidates and emerging technologies.
Madhusmita Subudhi, Akash Suresh, Sakshi Singh et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review evaluates the current state of vaccine development against six major protozoan pathogens, including Plasmodium falciparum and Toxoplasma gondii. It highlights recent advancements in understanding parasite biology and immunological research that may enhance vaccine design. The review identifies key gaps and suggests future research directions to improve vaccine efficacy.
Key findings
- Vaccine development for protozoan diseases has progressed slower than for other infectious agents.
- Recent advancements in immunological research offer renewed prospects for effective vaccine design.
- The review covers six major protozoan pathogens, including Plasmodium falciparum and Leishmania donovani.
- Identifies potential antigenic targets and emerging vaccine delivery technologies.
Why it matters
Understanding the challenges and advancements in protozoan vaccine research is crucial for addressing significant public health threats posed by these pathogens, particularly in resource-limited settings. Improved vaccines could reduce morbidity and mortality associated with protozoan infections.